Regulation of exocytosis by protein kinase C
5 Current therapeutic strategies targeting eryptosis in renal anemia To date, the management of renal anemia in chronic kidney disease (CKD) has primarily focused on correcting erythropoietin (EPO) deficiency and iron dysregulation
10.1016/j.cbi.2022.110148 92 WangY.SunT.JiangC
1 H NMR (400 MHz, D 2 O) 7.78 (s, 2H), 7.01 (s, 2H), 4.71 4.60 (m, 2H), 4.44 4.03 (m, 3H), 3.80 3.74 (m, 4H), 3.32 2.88 (m, 10H), 1.85 1.11 (m, 18H) 13 .C NMR (151 MHz, D 2 O) 178.88, 172.79, 172.16, 172.10, 167.38, 167.21, 134.76, 134.56, 129.96, 129.66, 117.45, 54.20, 54.17, 53.68, 53.46, 53.08, 40.64, 40.59, 39.33, 39.28, 37.38, 30.79, 30.39, 30.37, 28.05, 27.65, 27.48, 27.40, 22.63, 22.18, 22.04